Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company has a collaboration agreement with Gilead Sciences, Inc.; and research collaboration with Novo Nordisk to discover cell-specific carriers of nucleic acid therapeutics. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Novo Nordisk A/S

Intangible Assets

Intangible Assets %Chg

Intangible Assets Common Size

Property, Plant and Equipment

Property, Plant and Equipment %Chg

Property, Plant and Equipment Common Size

Investments in Associated Companies

Investments in Associated Companies %Chg

Investments in Associated Companies Common Size

Deferred Income Tax Assets

Deferred Income Tax Assets %Chg

Deferred Income Tax Assets Common Size

Other Receivables and Prepayments

Other Receivables and Prepayments %Chg

Other Receivables and Prepayments Common Size

Other Financial Assets

Other Financial Assets %Chg

Other Financial Assets Common Size

Total Non-Current Assets

Total Non-Current Assets %Chg

Total Non-Current Assets Common Size

Inventories

Inventories %Chg

Inventories Common Size

Trade Receivables

Trade Receivables %Chg

Trade Receivables Common Size

Tax Receivables

Tax Receivables %Chg

Tax Receivables Common Size

Marketable Securities

Marketable Securities %Chg

Marketable Securities Common Size

Derivative Financial Instruments

Derivative Financial Instruments %Chg

Derivative Financial Instruments Common Size

Cash at Bank

Cash at Bank %Chg

Cash at Bank Common Size

Other Current Assets

Other Current Assets %Chg

Other Current Assets Common Size

Total Current Assets

Total Current Assets %Chg

Total Current Assets Common Size

Total Assets

Total Assets %Chg

Total Assets Common Size

Share Capital

Share Capital %Chg

Share Capital Common Size

Treasury Shares

Treasury Shares %Chg

Treasury Shares Common Size

Retained Earnings

Retained Earnings %Chg

Retained Earnings Common Size

Other Reserves

Other Reserves %Chg

Other Reserves Common Size

Total Equity

Total Equity %Chg

Total Equity Common Size

Borrowings

Borrowings %Chg

Borrowings Common Size

Deferred Income Tax Liabilities

Deferred Income Tax Liabilities %Chg

Deferred Income Tax Liabilities Common Size

Retirement Benefit Obligations

Retirement Benefit Obligations %Chg

Retirement Benefit Obligations Common Size

Other Liabilities

Other Liabilities %Chg

Other Liabilities Common Size

Provisions

Provisions %Chg

Provisions Common Size

Total Non-Current Liabilities

Total Non-Current Liabilities %Chg

Total Non-Current Liabilities Common Size

Cash and Cash Equivalents

Cash and Cash Equivalents %Chg

Cash and Cash Equivalents Common Size

Short-Term Investments

Short-Term Investments %Chg

Short-Term Investments Common Size

Total Cash and Cash Equivalents

Total Cash and Cash Equivalents %Chg

Total Cash and Cash Equivalents Common Size

Accounts Receivable

Accounts Receivable %Chg

Accounts Receivable Common Size

Other Receivables

Other Receivables %Chg

Other Receivables Common Size

Total Trade Receivables

Total Trade Receivables %Chg

Total Trade Receivables Common Size

Net Property, Plant & Equipment

Net Property, Plant & Equipment %Chg

Net Property, Plant & Equipment Common Size

Net Intangible Assets

Net Intangible Assets %Chg

Net Intangible Assets Common Size

Long-Term Investments

Long-Term Investments %Chg

Long-Term Investments Common Size

Other Long-Term Assets

Other Long-Term Assets %Chg

Other Long-Term Assets Common Size

Accounts Payable

Accounts Payable %Chg

Accounts Payable Common Size

Trade Payables

Trade Payables %Chg

Trade Payables Common Size

Accrued Expenses

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

Assets	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Cash and Cash Equivalents	18,435	15,655	52,821	14,392	21,574	12,653
Cash at Bank
Short-Term Investments	12,775	16,979	12,193	18,182	17,436	13,648
Marketable Securities
Derivative Financial Instruments
Total Cash and Cash Equivalents	31,210	32,634	65,014	32,574	39,010	26,301
Accounts Receivable	69,575	71,949	63,565	64,770	61,294	50,560
Trade Receivables
Other Receivables	20,707	19,481	14,743	11,921	9,227	7,151
Tax Receivables
Other Receivables and Prepayments
Other Receivables and Prepayments
Total Trade Receivables	90,282	91,430	78,308	76,691	70,521	57,711
Inventories	45,652	40,849	36,356	31,811	28,020	24,388
Inventories
Other Current Assets	—	—	—	—	—	—
Other Current Assets
Total Current Assets	162,705	160,897	177,500	139,646	137,551	108,194
Total Current Assets
Net Property, Plant & Equipment	180,758	162,488	109,980	90,961	75,024	66,671
Property, Plant and Equipment
Net Intangible Assets	107,866	111,090	55,501	60,406	50,749	50,939
Intangible Assets
Long-Term Investments	2,638	2,677	1,659	1,663	1,479	1,343
Investments in Associated Companies
Other Financial Assets
Other Long-Term Assets	23,747	24,627	22,565	20,380	15,950	13,904
Deferred Income Tax Assets
Other Receivables and Prepayments
Total Assets	482,153	465,795	369,383	314,486	280,753	241,257
Total Assets

Liabilities	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Accounts Payable	28,206	28,846	29,759	25,606	17,788	15,587
Trade Payables
Accrued Expenses	32,987	38,016	29,953	28,894	22,527	23,706
Other Liabilities
Other Liabilities
Short-Term Debt	5,329	7,531	2,363	1,272	7,828	2,903
Borrowings
Derivative Financial Instruments
Other Current Liabilities	16,927	9,716	5,906	7,116	108,475	7,091
Tax Payables
Provisions
Total Current Liabilities	207,522	217,528	187,909	169,655	156,618	120,940
Total Current Liabilities
Long-Term Debt	99,268	102,787	57,060	27,006	19,415	25,784
Borrowings
Borrowings
Other Long-Term Liabilities	131,370	135,413	131,820	118,031	14,247	82,700
Deferred Income Tax Liabilities
Retirement Benefit Obligations
Provisions
Provisions
Provisions
Other Liabilities
Total Long-Term Liabilities	106,565	104,781	68,952	38,270	33,662	36,831
Total Non-Current Liabilities
Total Liabilities	314,087	322,309	256,861	207,925	190,280	157,771
Total Liabilities

Equity	Jun '25	Dec '24	Jun '24	Dec '23	Jun '23	Dec '22
Common Stock	446	446	446	451	451	456
Share Capital
Treasury Stock	-2	-2	-1	-5	-3	-6
Treasury Shares
Accumulated Other Comprehensive Income	3,169	-1,406	-73	1,276	1,907	2,449
Other Reserves
Retained Earnings	164,453	144,448	112,150	104,839	88,118	80,587
Retained Earnings
Total Common Shareholders' Equity	168,066	143,486	112,522	106,561	90,473	83,486
Total Equity
Total Shareholders' Equity	168,066	143,486	112,522	106,561	90,473	83,486
Total Liabilities and Shareholders' Equity	482,153	465,795	369,383	314,486	280,753	241,257
Total Equity and Liabilities